Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06705842 · ClinicalTrials.gov registry record · Phase 4
APPI-Cost Trial for Perforated Appendicitis
A Phase 4 study of Perforated Appendicitis, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 346
- Enrollment target
- 1
- Study location
NCT06705842 is a Phase 4 study of Perforated Appendicitis that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 346 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06705842, a Phase 4 study of Perforated Appendicitis, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 346 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study to assess the clinical effectiveness and cost-effectiveness of povidone-iodine (PVI) irrigation in perforated appendicitis, to investigate barriers and facilitators to future implementation of PVI irrigation, and to collect costs and clinical and patient-reported outcomes among patients with non-perforated appendicitis.
Conditions Studied
Interventions
- DRUG PVI
- DRUG Usual Care
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 346 participants |
| Start Date | 2025-04-07 |
| Est. Completion | 2027-03-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06705842
The ClinicalTrials.gov registry entry for NCT06705842 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 346 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Perforated Appendicitis appearing as the primary indexed condition, and to 2 interventions - of which PVI is the first listed.
NCT06705842 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06705842 about?
NCT06705842 is a clinical study titled "APPI-Cost Trial for Perforated Appendicitis". The purpose of this study to assess the clinical effectiveness and cost-effectiveness of povidone-iodine (PVI) irrigation in perforated appendicitis, to investigate barriers and facilitators to future implementation of PVI irrigation, and to collect costs and clinical and patient-reported outcomes a...
What is the current status of trial NCT06705842?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 346 participants. The study started on 2025-04-07. Estimated completion is 2027-03-31.
What conditions does trial NCT06705842 study?
This clinical trial studies the following conditions: Perforated Appendicitis.
What interventions are being tested in trial NCT06705842?
The interventions under investigation include: PVI (DRUG), Usual Care (DRUG).
Who is sponsoring clinical trial NCT06705842?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06705842 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Perforated Appendicitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.